Drug
Naratriptan clinical trials
Also written AMERGE.
How studies write it
Studies that test it under each name
Studies by the year they started
6 studies that test it; most in 2006 (2)
| Year | Studies |
|---|---|
| 2006 | 2 |
| 2007 | 2 |
| 2014 | 1 |
| 2016 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 3
Roxane Laboratories (2) · UMC Utrecht (1) · Cady, Roger, M.D. (1) · Hartford HealthCare (1) · Ache Laboratorios Farmaceuticos S.A. (1)
Often tested with
Tested in the same studies.
Bupivacaine (1) · Dexamethasone (1) · Ketorolac (1) · Naproxen (1)
Related medicines
As reviewed, each with the page that says it.
Studies
Open first, then newest update. How each study uses naratriptan is read from its arms, and is right about nine times in ten.
Testing it · 6
- Status Migrainosus - Differentiating Between Responders and Non-respondersStatus unknownPhase 1/2Hartford HealthCareNCT03066544Written as Naratriptan Pill
- Bioequivalency Study of Naratriptan Hydrochloride 2.5 mg Under Fasted ConditionsCompletedNot applicableRoxane LaboratoriesNCT01161667Written as naratriptan hydrochloride
- Bioequivalency Study of Naratriptan Hydrochloride 2.5 mg Under Fed ConditionsCompletedNot applicableRoxane LaboratoriesNCT01161654Written as naratriptan hydrochoride
- Efficacy and Safety of a Fixed-dose Combination of Naratriptan and Naproxen in Acute Treatment of Migraine.WithdrawnPhase 3Ache Laboratorios Farmaceuticos S.A.NCT01726920Written as naratriptan + naproxen
- Efficacy of a Triptan in the Treatment of Hostility and Aggression Among Convicts With a Psychiatric Treatment OrderTerminatedPhase 4UMC UtrechtNCT00282165Written as naratriptan
- Naratriptan for the Treatment of Post Traumatic Headache Associated With Cognitive DysfunctionTerminatedPhase 4Cady, Roger, M.D.NCT00487578Written as naratriptan HCl
As the comparator · 1 — what is tested is compared with naratriptan
Codes
What other systems call naratriptan · ClinicalTrials.gg INT003998
- MeSH (NLM) C106783naratriptanConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) QX3KXL1ZA2NARATRIPTANConfirmed FDA, NLM, Wikidata
- RxNorm 141366Confirmed FDA, Wikidata
- Wikidata Q421315naratriptanConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C61857NaratriptanOne source FDA
- DrugBank DB00952One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C106783 | naratriptan | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | QX3KXL1ZA2 | NARATRIPTAN | Confirmed FDA, NLM, Wikidata |
| RxNorm | 141366 | — | Confirmed FDA, Wikidata |
| Wikidata | Q421315 | naratriptan | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C61857 | Naratriptan | One source FDA |
| DrugBank | DB00952 | — | One source Wikidata |
Also registered as naratriptan hydrochloride (UNII 10X8X4P12Z · RxNorm 236690).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.